Literature DB >> 9486390

Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-assocated markers of immune dysfunction.

M Westby1, J B Marriott, M Guckian, S Cookson, P Hay, A G Dalgleish.   

Abstract

We used three-colour cytometry to analyse intracellular cytokine production in activated whole blood cultures derived from patients with HIV-1 infection. We assessed mitogen-induced IL-2, IL-4 and IFN-gamma production from T cells as possible markers of immune dysfunction. The percentages of T cells staining for IL-2 were significantly reduced in stimulated cultures from HIV+ individuals relative to normal controls (P<0.0001); this reduction was observed in both the CD4+ and the CD8+ subsets. IL-2 production was significantly reduced in CD4+ T cells from HIV+ individuals clinically classified as symptomatics compared with HIV+ asymptomatics (P<0.001); in addition, production of IL-2 inversely correlated with viral load (r2=0.832). On the other hand, HIV+ individuals showed significantly more T cells staining positive for IFN-gamma (P<0.0001); subset analysis identified these T cells as CD8+. Increased IFN-gamma production in the CD8+ T cell subset of HIV+ individuals correlated neither with clinical status nor with plasma viral load. IL-4 staining in activated T cells was low (<5%) and no differences were observed between HIV+ and control groups. Three-colour FACS analysis of whole blood provides a sensitive, rapid and relatively easy means to detect cytokine profiles within T cell subpopulations. Only small volumes of blood are required (0.5 ml), since there is no need for cell isolation, making it more practical than ELISA or reverse transcriptase-polymerase chain reaction (RT-PCR) for the analysis of immune function in HIV+ individuals. This technique could therefore play a role in mapping the dynamics and extent of immune recovery in AIDS patients undergoing triple combination therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486390      PMCID: PMC1904916          DOI: 10.1046/j.1365-2249.1998.00505.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

Authors:  T W Chun; L Carruth; D Finzi; X Shen; J A DiGiuseppe; H Taylor; M Hermankova; K Chadwick; J Margolick; T C Quinn; Y H Kuo; R Brookmeyer; M A Zeiger; P Barditch-Crovo; R F Siliciano
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

Review 2.  Viruses use stealth technology to escape from the host immune system.

Authors:  E J Wiertz; S Mukherjee; H L Ploegh
Journal:  Mol Med Today       Date:  1997-03

3.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D R Lucey; C S Via; G M Shearer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  T cells from individuals in advanced stages of HIV-1 infection do not proliferate but express activation antigens in response to HIV-1-specific antigens.

Authors:  A Caruso; S Licenziati; A D Canaris; M Corulli; M A De Francesco; A Cantalamessa; F Fallacara; S Fiorentini; A Balsari; A Turano
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-05-01

5.  Regulation of CD4 and CD8 expression on mouse T cells. Active removal from the cell surface by two mechanisms.

Authors:  S J Anderson; C Coleclough
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

6.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

Authors:  M Clerici; F T Hakim; D J Venzon; S Blatt; C W Hendrix; T A Wynn; G M Shearer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  T cell activation and disease severity in HIV infection.

Authors:  M Mahalingam; M Peakman; E T Davies; A Pozniak; T J McManus; D Vergani
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

8.  Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection.

Authors:  J Fan; H Z Bass; J L Fahey
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

Review 9.  Brefeldin A: insights into the control of membrane traffic and organelle structure.

Authors:  R D Klausner; J G Donaldson; J Lippincott-Schwartz
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

10.  Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis.

Authors:  N K Banda; J Bernier; D K Kurahara; R Kurrle; N Haigwood; R P Sekaly; T H Finkel
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects.

Authors:  P De Paoli
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

2.  Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.

Authors:  P Brazille; N Dereuddre-Bosquet; C Leport; P Clayette; O Boyer; J-L Vildé; D Dormont; O Benveniste
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

3.  Large granular lymphocytes are universally increased in human, macaque, and feline lentiviral infection.

Authors:  Wendy S Sprague; Cristian Apetrei; Anne C Avery; Robert L Peskind; Sue Vandewoude
Journal:  Vet Immunol Immunopathol       Date:  2015-07-29       Impact factor: 2.046

4.  Cytokine analysis at the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals.

Authors:  C Amiel; J P Kusnierz; Y Mouton; G Rook; J Stanford; M Singh; A Capron; G M Bahr
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

5.  Comparison of serum and cell-specific cytokines in humans.

Authors:  J Jason; L K Archibald; O C Nwanyanwu; M G Byrd; P N Kazembe; H Dobbie; W R Jarvis
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

6.  Lack of evidence for the Th2 predominance in patients with chronic hepatitis C.

Authors:  A Bergamini; F Bolacchi; G Cerasari; C Carvelli; E Faggioli; M Cepparulo; F Demin; I Uccella; B Bongiovanni; P Niutta; M Capozzi; M Lupi; E Piscitelli; G Rocchi; M Angelico
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

7.  Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitro.

Authors:  M Guckian; I Dransfield; P Hay; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

8.  Enhanced interferon-gamma by CD8+ CD28- lymphocytes from HIV+ patients.

Authors:  E H Eylar; C Lefranc; I Báez; S L Colón-Martinez; Y Yamamura; N Rodriguez; N Yano; T B Breithaupt
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

9.  Differential modulation of surface and intracellular protein expression by T cells after stimulation in the presence of monensin or brefeldin A.

Authors:  Nancy J O'Neil-Andersen; David A Lawrence
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

10.  CD8+ T cell-derived IFN-γ prevents infection by a second heterologous virus.

Authors:  Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  J Immunol       Date:  2012-11-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.